newsfilter
← Latest News
ACCESS Newswire·

Novamind Hosts Pioneering Psychedelic Clinical Trial for Opioid Use Disorder

TORONTO, ON / ACCESSWIRE / January 13, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today announced it will host a phase I randomized clinical tria